arrow
J

Jingxian Liu

the provided affiliation string "department of clinical laboratory" does not contain a higher-level institution such as a university or company. therefore, the output is empty.
H指数:22
被引数:1,743

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular mechanisms of CBASS phospholipase effector CapV mediated membrane disruption

CBASS磷脂酶效应蛋白CapV介导的膜破坏分子机制

2025-09-290
OAAI
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial

用灭活SARS-CoV-2疫苗 (CoronaVac) 引发的60岁及以上健康成年人Ad5-nCOV异源免疫的免疫原性和安全性: 一项4期,随机,观察者盲,非劣效性试验

2023-09-017
OAAI
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
2023-07-0124
OAAI